Ohio-based Nordson Corporation (NDSN) is a powerhouse of precision technology, fueling top-tier growth and returns through its agile, division-led model. With a direct sales approach and unmatched application expertise, the company delivers high-margin solutions across critical industries. From consumer goods to cutting-edge medical devices, electronics, and industrial applications, Nordson’s diverse market reach and innovation-driven mindset keep it ahead of the curve worldwide.

With a market cap of approximately $11 billion, shares of Nordson have tanked roughly 18.7% over the past year and 7.6% in 2025. In contrast, the broader S&P 500 Index ($SPX) has gained roughly 10.2% over the past 52 weeks and dropped 1.3% YTD.

Zooming in further, NDSN stock is also underperforming the S&P 500 Industrial Sector SPDR’s (XLI) 13.7% return over the past year and 6.9% gain on a YTD basis. 

Nordson’s fiscal 2025 first-quarter earnings, released on February 19, failed to impress, doing little to spark investor enthusiasm as the stock barely moved post-announcement. The company reported adjusted earnings of $2.06 per share, which not only marked a 6.8% year-over-year decline but also missed Wall Street’s $2.08 forecast. Revenue followed a similar trend, slipping 2.8% to $615.4 million and falling short of the $636.3 million consensus estimate. Looking ahead, the company is gearing up to release its Q2 earnings results after the market closes on May 28.

For the current fiscal year, ending in October, analysts expect NDSN’s EPS to grow 1.9% to $9.91. The company’s earnings surprise history is mixed. It beat the consensus estimate in three of the last four quarters, while missing on one other occasion. 

Among the eight analysts covering NDSN stock, the consensus view is a “Moderate Buy.” That’s based on four “Strong Buy” and four “Hold” ratings. This configuration has remained steady over the past three months. 

On March 3, KeyBanc Capital Markets turned bullish on Nordson Corporation, upgrading the stock from “Sector Weight” to “Overweight” and setting a fresh price target of $260, signaling a 34.5% upside from current levels.

NDSN’s mean price target of $249.28 represents a premium of 29% from the current market prices. Meanwhile, the Street-high target of $285 suggests an even greater leap of 47.4% from current price levels.